Received May 5, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | C47XX | — |
Hiberix liquid portion only administration (potential)/received only the diluent of Hiberix; Hiberix liquid portion only administration (potential)/received only the diluent of Hiberix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 6-month-old male patient who received Hib (Hiberix) (batch number C47XX, expiry date 20-OCT-2026) for prophylaxis. On 27-FEB-2026, the patient received Hiberix. On 27-FEB-2026, an unknown time after receiving Hiberix, the patient experienced inappropriate preparation of medication (Verbatim: Hiberix liquid portion only administration (potential)/received only the diluent of Hiberix) and inappropriate dose of vaccine administered (Verbatim: Hiberix liquid portion only administration (potential)/received only the diluent of Hiberix). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 27-APR-2026 Healthcare provider wanted to know how to proceed with patient that received only the diluent of Hiberix. She was not aware of which 2 of 9 patients received it, thus, the adverse event details of each of those nine was taken. This case is one of linked case of 9 cases reported by same reporter.; Sender's Comments: US-GSK-US2026057333:Same reporter/Different patient US-GSK-US2026057336:Same reporter/Different patient US-GSK-US2026057337:Same reporter/Different patient US-GSK-US2026057335:Same reporter/Different patient US-GSK-US2026057339:Same reporter/Different patient US-GSK-US2026057503:Same reporter/Different patient US-GSK-US2026057340:Same reporter/Different patient US-GSK-US2026057667:Same reporter/Different patient